Metals and Parkinson's Disease: Mechanisms and Biochemical Processes

Author(s): Geir Bjorklund*, Vera Stejskal, Mauricio A. Urbina, Maryam Dadar, Salvatore Chirumbolo, Joachim Mutter

Journal Name: Current Medicinal Chemistry

Volume 25 , Issue 19 , 2018

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


Genetic background accounts for only 5 to 10% of the reported cases of Parkinson's disease (PD), while the remaining cases are of unknown etiology. It is believed that environmental factors may be involved in the causality of a large proportion of PD cases. Several PD genes are activated by xenobiotic exposure, and a link between pesticide exposure and PD has been demonstrated. Many epidemiological studies have shown an association between PD and exposure to metals such as mercury, lead, manganese, copper, iron, aluminum, bismuth, thallium, and zinc. This review explores the biological effects, the pathogenetic processes, genetic susceptibilities to metals as well as examining future strategies for PD treatment, such as chelation therapy.

Keywords: Substantia nigra, alpha-synuclein, beta-amyloid, glutamate, glutathione, oxidative stress, metals, dopamine.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Published on: 30 May, 2018
Page: [2198 - 2214]
Pages: 17
DOI: 10.2174/0929867325666171129124616
Price: $65

Article Metrics

PDF: 102
HTML: 26
PRC: 1